More about GlaxoSmithKline Pharmaceuticals Limited

Technicals for GlaxoSmithKline Pharmaceuticals Limited

The STOCHASTIC is showing a neutral stance, not indicating a clear upward...

GlaxoSmithKline Pharmaceuticals Limited's forward EPS is higher than its trailing EPS, which...

The list of all important regulatory filings for GlaxoSmithKline Pharmaceuticals Limited which...

An analysis of the anticipated Trump-Putin talks in Alaska on August 15,...

An analysis of the potential impacts of the Trump-Putin summit in Alaska...

The Alaska Summit on August 15, 2025, is anticipated to significantly influence...

Last Updated:

2025-08-15 21:13

Published	Title	Summary
2025-01-20 15:40:54	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2025-01-15 12:39:50	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2024-07-22 13:05:12	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
2024-05-17 14:11:26	Record Date	GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date...
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 31-May-2024.